Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
05:57pm, Wednesday, 21'st Feb 2024
BOSTON , Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th A
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
05:55pm, Wednesday, 21'st Feb 2024
BOSTON , Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Me
Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised
11:41am, Friday, 09'th Feb 2024
Haemonetics' (HAE) proprietary technology, Persona, continues to gain momentum in the third quarter.
Here's Why Haemonetics (HAE) is a Strong Value Stock
10:40am, Friday, 09'th Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript
12:24pm, Thursday, 08'th Feb 2024
Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript
Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:36am, Thursday, 08'th Feb 2024
Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall S
Haemonetics (HAE) Surpasses Q3 Earnings and Revenue Estimates
08:10am, Thursday, 08'th Feb 2024
Haemonetics (HAE) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.85 per share a year ago.
HAE vs. ABT: Which Stock Is the Better Value Option?
12:46pm, Tuesday, 06'th Feb 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Abbott (ABT). But which of these two stocks presents investors with the better value op
3 Stocks to Buy for Consistent Sales Growth
05:26pm, Thursday, 01'st Feb 2024
Consistency is key, particularly whenever it concerns generating sales. For those seeking top line compounders, these three companies fit the criteria nicely.
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
11:06am, Thursday, 01'st Feb 2024
Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Wednesday, 31'st Jan 2024
Haemonetics (HAE) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why Haemonetics (HAE) is a Strong Growth Stock
11:18am, Friday, 12'th Jan 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 Medical Product Stocks to Buy Amid Industry Challenges
09:01am, Monday, 08'th Jan 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. PHG, NEOG, HAE and PBH are well-poised to
Haemonetics (HAE) Up 11% in a Year: Will the Rally Continue?
03:02pm, Wednesday, 03'rd Jan 2024
Investors are optimistic about Haemonetics (HAE) owing to its strategic focus on establishing leading positions in high-growth markets and raised guidance.
HAE or SYK: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 03'rd Jan 2024
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
